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FIGURE 1. Multiple stents in the LAD, OM, and terminal branches of the LCx coronary artery (A), with significant in-stent stenosis in the LAD and com-
plete in-stent occlusion of the OM and terminal branches (B).
Brief CommunicationsPneumothorax in two siblings: Is there a genetic basis for recurrence?
John Henderson, BMBS,a Pradeep Narayan, FRCS,a Sarah F. Smithson, FRCP,b and Anthony Morgan, FRCS,a
Bristol, United KingdomThe incidence of primary pneumothorax is reported as 18 to
28 per 100,000 per year for men and 1.2 to 6 per 100,000 per
year for women, with approximately 10% having a positive
family history.1 Although recurrent pneumothoraces on the
ipsilateral side is seen in less than 5% of cases and may
be dependent on the surgical technique, contralateral recur-
rence may arise because of individual or familial predis-
position. Autosomal dominant inheritance of recurrent
pneumothorax within families has been associated with the
mutation of the folliculin (FLCN) gene.2 Patients who
have blebs, bullae, and recurrent pneumothorax with or
without a family history may have mutations in this gene.3
We describe 2 siblings who had multiple ipsilateral and con-
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this family, no mutations in the FLCN gene were found.
CLINICAL SUMMARY
Patient 1
A 14-year-old girl presented with a small left-sided pneu-
mothorax that was successfully treated with needle aspiration.
She returned 2months later with ipsilateral recurrence and un-
derwent video-assisted thoracoscopic surgery. A left upper
third pleurectomy and apicectomy were carried out. Two
weeks later, a contralateral right-sided pneumothorax devel-
oped, and she underwent right video-assisted thoracoscopic
surgery, apicectomy, and pleurectomy. A recurrence on the
left side developed 9 months later. Computed tomography
showed no pleural bulla or interstitial lung disease. Open tho-
racotomy revealed a complete regrowth of parietal pleura. A
complete pleurectomy was carried out, and she remains well
6 years after the procedure.
Patient 2
The elder brother of patient 1 presented at 17 years of age
with a small left pneumothorax that was treated withardiovascular Surgery c Volume 137, Number 4 1021
Brief Communicationsaspiration alone. He presented 1 year later with bilateral
pneumothoraces. Bilateral video-assisted pleurectomy and
apicectomy were carried out. Histology demonstrated
emphysematous blebs apical bullae with no evidence of
underlying disease. Eight months later, he presented with
a recurrent left-sided pneumothorax that was treated with
thoracotomy and pleurectomy. No bullae were seen; how-
ever, he presented 5 months later with another recurrence
on the left side that was treated with tetracycline pleurodesis.
One month later he was readmitted with a right-sided recur-
rent pneumothorax and treated with a right thoracotomy and
pleurectomy. He has remained well for 6 years. Both sib-
lings were of normal stature and build, and had no relevant
clinical features of a connective tissue disorder.
GENETIC TESTING
Mutation screening by sequencing of the whole FLCN
gene in patients 1 and 2 and their unaffected sibling and
parents was negative, and no potentially disease-causing
mutations were identified.
DISCUSSION
Ipsilateral recurrences are commonly ascribed to surgical
techniques. In addition to either open or video-assisted pleur-
ectomy and bullectomy, various other adjuncts, such as cover-
ing the staple line with absorbable mesh,4 talc poudrage, and
chemical pleurodesis with blood or tetracycline, are applied
to diminish recurrence. However, apart from smoking and
the presence of pleural blebs and bullae, genetic factors that
are only partly understoodmay be responsible for recurrences,
especially on the contralateral side.
Familial spontaneous pneumothorax is a recognized com-
plication of Marfan syndrome (because of mutations in the
fibrillin 1 gene) and has been reported as a dominant trait
in families without features ofMarfan syndrome or any other
connective tissue disorder.5 In these latter families, molecu-
lar genetic testing did not identify anymutations in fibrillin 1,
suggesting that another single gene may be involved. In the
siblings we report, no features of Marfan syndrome were1022 The Journal of Thoracic and Cardiovascular Sseen, and therefore analysis of fibrillin 1 was not
undertaken. Mutations in the gene encoding FLCN located
at chromosome 17p11.2 have been found to cause familial
recurrent pneumothorax.2,3 Different mutations in this gene
also cause the broader phenotype of Birt-Hogg-Dube syn-
drome, an autosomal dominant condition with additional
manifestations, including skin fibrofolliculomas, thyroid,
and renal tumors, as well as recurrent pneumothoraces. Cur-
rently, patients with isolated spontaneous pneumothorax and
FLCN mutations are not known to be at risk of Birt-Hogg-
Dube complications, although the genotype–phenotype rela-
tionships are not fully understood.2 In the siblings reported,
no FLCN mutations were identified, so the basis of their fa-
milial predisposition is not clear, but further relevant genes
may be identified in the future.
Although recurrence after surgical intervention in part is
related to certain modifiable risk factors and surgical tech-
niques, the role of pleural blebs and bullae and the genetic
predisposition of individuals and families must be consid-
ered. Genetic testing may have a future role in identifying in-
dividuals at high risk of pneumothorax, guiding aggressive
operative management, and providing genetic information
to patients’ families.
We thank Dr Jodie Painter and the Folkha¨lsan Institute of Genet-
ics, Finland, for undertaking the laboratory genetic investigations.
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